Wilbanks Smith & Thomas Asset Management
MYOK

Wilbanks Smith & Thomas Asset Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,000
Closed -$65K – 1479
2018
Q3 		$65K Buy
+1,000
New +$58.8K ﹤0.01% 628

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BB Biotech
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Wilbanks Smith & Thomas Asset Management's MYOK Position: Q4 2018 in Review

Wilbanks Smith & Thomas Asset Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2018, closing a stake of 1,000 shares — an estimated $65K sold.

Wilbanks Smith & Thomas Asset Management first reported a position in MYOK in Q3 2018 and held it in 1 quarter. The position peaked at $65K in Q3 2018. 145 funds tracked by Wall St. Rank hold MYOK as of Q4 2018.

  • Wilbanks Smith & Thomas Asset Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Wilbanks Smith & Thomas Asset Management sold 1,000 MyoKardia, Inc. Common Stock shares in Q4 2018, an estimated $65K.
  • Wilbanks Smith & Thomas Asset Management first reported a position in MyoKardia, Inc. Common Stock in Q3 2018 and held it in 1 quarter.
  • Wilbanks Smith & Thomas Asset Management's MyoKardia, Inc. Common Stock position peaked at $65K in Q3 2018.
  • 145 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2018.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q4 2018, filed 8 Feb 2019.